These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8459037)

  • 1. Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.
    Limas C; Bigler A; Bair R; Bernhart P; Reddy P
    J Clin Pathol; 1993 Feb; 46(2):159-65. PubMed ID: 8459037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
    Cohen MB; Waldman FM; Carroll PR; Kerschmann R; Chew K; Mayall BH
    Hum Pathol; 1993 Jul; 24(7):772-8. PubMed ID: 8100555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
    Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
    Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic nucleolar organiser regions in transitional cell bladder tumours related to established prognostic factors, progression and independent prognostic value.
    Lipponen PK; Eskelinen MJ
    Oncology; 1992; 49(2):133-8. PubMed ID: 1574249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
    Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
    Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors.
    Limas C; Bair R; Bernhart P; Reddy P
    J Clin Pathol; 1993 Sep; 46(9):810-6. PubMed ID: 8227429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphometric, cytochemical and immunohistochemical studies on the proliferative activity of urinary bladder carcinomas].
    Krüger S; Kahl M; Fabian T; Hörlin A; Herrmann G; Müller H; Schneider M
    Verh Dtsch Ges Pathol; 1993; 77():231-5. PubMed ID: 7511287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
    Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
    Goyal S; Singh UR; Sharma S; Kaur N
    Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: comparison with the Ki67 antigen and BrdU incorporation.
    Smith MD; Healy E; Thompson V; Morley A; Rees JL
    Br J Dermatol; 1995 Mar; 132(3):359-66. PubMed ID: 7718451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
    Helpap B; Loesevitz L; Bulatko A
    Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).
    Mulder AH; Van Hootegem JC; Sylvester R; ten Kate FJ; Kurth KH; Ooms EC; Van der Kwast TH
    J Pathol; 1992 Jan; 166(1):37-43. PubMed ID: 1538273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of flow-cytometric determination of Ki67 expression as a measure of growth factor response in acute myelogenous leukemia.
    Gore SD; Weng LJ; Burke PJ
    Exp Hematol; 1993 Dec; 21(13):1702-8. PubMed ID: 7694870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Ki67 antigen using MIB1 antibody as a prognostic factor in renal pelvic and ureteral cancer].
    Kojima K; Naruo S; Kanayama H; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):822-30. PubMed ID: 8691707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
    Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
    Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
    Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.